Sitemap
- Adrian Adams named new CEO of Sepracor
- International Approvals: Aerius, Sebivo, Rapydan
- The Most Powerful African Americans In Corporate America
- Schering-Plough Announces EU Approval of Two New Formulations of ...
- Drug companies struggle to replace lost revenue
- Sepracor launches Brovana to market
- Mixtape Report:
- High Pollen Count Leads to Early Start of Allergy Season
- Zacks Analyst Blog Highlights: Schering-Plough, Merck, CNOOC and ...
- Big Pharma teaches old drugs new tricks
- Generic makers crave bigger slice
- Spurred by opportunity and necessity, generic drug makers take on ...
- Industry Wrapups
- Talk about the show
- Techdirt.com -- Easily digestible tech news
- More People Recognizing Patents Might Not Help In Healthcare
- More People Recognizing Patents Might Not Help In Healthcare
- Bad Medicine
- Nasal congestion is nothing to sneeze at
- Meet 75 executives who hold tremendous clout in the world of business ...
- Going generic
- China Biopharmaceuticals Holdings Initiates Clinical Trials of ...
- Cure for high drug costs
- MORE BUSINESS NEWS
- 3rd UPDATE: Cholesterol Drugs Lift Schering-Plough's 3Q
- Schering-Plough Posts Major Increase in Net Income
- Schering-Plough net rises on Vytorin, Zetia
- Malco sees the future in digital
- Schering-Plough sues GeoPharma over allergy drug
- Sepracor gets FDA approval for Brovana
- GeoPharma Sued by Schering-Plough
- StreetInsider.com Unusual 11 Mid-Day Movers 10/10
- Schering-Plough to sue GeoPharma over Clarinex patent infringement
- GeoPharma Announces Schering-Plough Lawsuit Related to Generic Version ...
- GeoPharma Announces Schering-Plough Lawsuit Related to Generic Version ...
- Subscribe to this paper
- Sepracor gets FDA approval for Brovana
- StreetInsider.com Unusual 11 Mid-Day Movers 10/10
- Drug industry tactics cost NHS millions
- As brand-name drugs go generic, everybody saves
- Yorktown police nab suspected 'major drug dealer' - YORKTOWN
- GM's bitter pill
- Schering-Plough CEO Cures Host of Ills
- Schering-Plough Launches Important Multinational Studies to Evaluate ...
- LegalView.com Announces New 'DrugWatch' Feature
- Drug maker settles for $435 million
- Drug firm settles; state to get $2M
- Manhattan Research Reveals Top Pharmaceutical Websites Visited by ...
- Schering to pay $435 million to settle sales and billing case
- Schering-Plough to pay $435 million
- Serwer: 2 winners and a very soft shoe
- Gary Crandall, CEO
- Ragweed's here! Sneeze the day!
- GSW Worldwide's Pennsylvania Office Announces Executive New Hires
- Generic Medication Savings Opportunities Grow
- Generic Medication Savings Opportunities Grow
- Merck, Schering-Plough see healthy profits boost
- Schering-Plough Announces Global Agreement With Novartis to Develop ...
- Schering-Plough's cholesterol problem
- Clarinex - Drug Description
- Hives: They can get under your skin
- Dear Dr. Gott: Apple cider vinegar not helpful
- FAMILY DOCTOR: Cider vinegar not harmful, but also not helpful
- Merck, Schering cholesterol drugs help boost profits
- Arkansas sheriffs surveyed on Meth
- Allergy drug tackles nasal congestion: study
- Perrigo Reports Record Second Quarter Sales
- UPDATE 1-Mylan says settles Clarinex patent litigation
- Mylan Announces Clarinex(R) Settlement Agreement
- Mylan settles allergy drug dispute
- Mylan Inc declares settlement agreement for Desloratadine Tablets, 5 ...
- UPDATE 1-Schering settles final Clarinex patent litigation
- Zacks Analyst Blog Highlights: Schering-Plough Corp., Caraco ...
- 'Natural Organizer' Passionate About Music, Gators
- Employers must step up on health care
- Zacks Analyst Blog Highlights: PG&E, Con Ed, Schering-Plough, Merck ...
- Glaxo’s Migraine Pill Spurned by UnitedHealth for Generic Combo
- These 5 Stocks Have a Little Magic
- Cocoa prices rise; El Niño weather, Ivory Coast elections behind ...
- Schering-Plough Corporation Company Profile - View Schering-Plough ...
- Drugs and Treatments - Clarinex
- Uses and How to Use
- When to Have Surgery for Hiatal Hernia? - Health - redOrbit
- McKesson Sued for Alleged Drug Price Manipulation
- This Promotional Pen Works So Great, Imagine How Well The Drug Must Work | The Onion - America's Finest News Source
- Allergy Drug May Deliver More Relief - washingtonpost.com
- New Hotel Rooms Promise To Keep Bacteria In Check - Health News Story - KGTV San Diego
- Allergy Medicine Got You Down?
- Chemical & Engineering News: Science & Technology - Brain Barricade
- Beaver County Times Allegheny Times - Drug sweep nets 14
- Adrian Adams named new CEO of Sepracor - Boston Business Journal:
- E.U. drug panel doesn't back Amgen's Vectibix for colon cancer - MarketWatch
- PharmaLive: Committee for Medicinal Products for Human Use Summary of Positive Opinion for Aerinaze
- SignOnSanDiego.com > News > Business -- NJ court allows whistleblower suit against Schering-Plough
- Whistle-blowers can press suit against Shering | Home News Tribune Online
- Business Briefing
- Beacon News :: Business :: Tribune buyout moves ahead
- North Jersey Media Group providing local news, sports & classifieds for Northern New Jersey!
- Don't suffer sneezin' season -- Shanghai Daily | ???? -- English Window to China News
- www.wbjournal.com - New positions for drug co. execs
- PharmaLive: Sepracor Announces Management Transition
- Worcester Telegram & Gazette News
- Sepracor Names Adams CEO
- Adrian Adams named new CEO of Sepracor - Boston Business Journal:
- Schering-Plough announces European approval of new formulations of AERIUS (Desloratadine)
- Pharmacy: Allergy sufferers get little sympathy | Chron.com - Houston Chronicle
- Big Number at Schering-Plough
- Schering-Plough Announces EU Approval of Two New Formulations of AERIUS(R) (Desloratadine)
- Beacon News :: Lifestyles :: What millions of us have in common
- Sepracor launches Brovana to market - Boston Business Journal:
- York Dispatch - For outdoor allergy sufferers, the onslaught is just beginning
- Spring Allergies
- Winston-Salem Journal | Generic-drug-makers push for change
- ABC News: Fight Allergies With Expert Tips
- Daytrading, Eminis, Forex trading, Swing Trading BREAKING NEWS - 517267
- News: Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone. Genetic Engineering News - Biotechnology from Bench to Business
- Mylan, Pfizer launch generic Norvasc
- Court rules against Pfizer on Norvasc patent case | Reuters.ca
- Generic Norvasc seen soon, as decision hits Pfizer| Reuters
- Analyst Sees Generic Norvasc Launch on Sunday | Health & Drugs | Reuters.co.uk
- Court Rules Against Pfizer on Norvasc Patent Case | Health & Drugs | Reuters.co.uk
- Appeals Court Reverses Patent Ruling - Forbes.com
- Mylan Shares Jump on Pfizer Patent Loss | Chron.com - Houston Chronicle
- Mylan Shares Jump on Pfizer Patent Loss - Forbes.com
- Generic Norvasc Seen Soon, as Decision Hits Pfizer
- Appeals court reverses patent ruling
- Appeals Court Reverses Patent Ruling | Chron.com - Houston Chronicle
- Appeals court reverses patent ruling
- Appeals Court Reverses Patent Ruling - Forbes.com
- Court Overturns Decision On Pfizer Drug Patent - Preview
- The New York Times > Log In
- Generic Norvasc Seen Soon, as Decision Hits Pfizer | Health & Drugs | Reuters.co.uk
- TheStar.com - Business - Apotex wins appeal over Norvasc generic drug
- Ahead of the Bell: Mylan - Forbes.com
- Mylan Launches Generic of Pfizer's Norvasc | Health & Drugs | Reuters.co.uk
- Mylan, Pfizer Launch Generic Norvasc | Chron.com - Houston Chronicle
- Mylan Launches Generic Norvasc - Forbes.com
- Pfizer launches its own generic version of Norvasc - Mar. 23, 2007
- Mylan, Pfizer Launch Generic Norvasc | Chron.com - Houston Chronicle
- Mylan, Pfizer launch generic Norvasc
- Mylan, Pfizer Launch Generic Norvasc - Forbes.com
- Euro2day :: Politics, need spur generic drug lobby
- Philadelphia Inquirer | 03/05/2007 | This drug war pits generics vs. brand names
- PharmaLive: Inspire to Present Data at 2007 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
- Snore No More--Part II
- Bloomberg.com: U.S.
- Bloomberg.com: U.S.
- Bloomberg.com: Worldwide
- Bloomberg.com: U.S.
- Schering-Plough Corporation :: Schering-Plough Reports Financial Results for 2006 Fourth Quarter, Full Year
- Schering-Plough Q4 profit up - Pharmaceutical Business Review
- Technical, Fundamental, and Sentiment Analysis on Schering-Plough Ahead of Earnings
- BUY FIORICET, Cheap Fioricet, Fioricet Online : Indymedia Colombia
- Therapeutics Daily
- Texas settles with pharmaceutical company - Austin Business Journal:
- Democrat & Chronicle: Business
- News for Austin, Texas | kvue.com | Top Stories
- keyetv.com - AG Releases Top-10 Child Support Evader List
- Former Austin man tops list of Texas child support evaders
- KXAN.com - Austinite On List Of Top Child Support Evaders
- KTRE-TV - Lufkin/Nacogdoches, TX - Confidential News Informants
- STATE NEWS | KHOU.com | News for Houston, Texas
- News 8 Austin | 24 Hour Local News | LOCAL NEWS
- Hometown News
- orangeleader.com (Orange, Texas) - AG puts Orange man on Top 10 list
- MySA.com: Metro | State
- KXAN.com - Austinite On List Of Top Child Support Evaders
- Texas turns up the heat on deadbeat parents | Chron.com - Houston Chronicle
- PR Newswire : New Data Show Incidence of Drowsiness and Sedation is Higher for Some Patients Taking Xyzal(R) (Levocetirizine) Than Patients Prescribed AERIUS(R) [NEOCLARITYN(R)] (Desloratadine) Within one Month of Treatment
- PR Newswire : New Data Show Incidence of Drowsiness and Sedation is Higher for Some Patients Taking Xyzal(R) (Levocetirizine) Than Patients Prescribed AERIUS(R) [NEOCLARITYN(R)] (Desloratadine) Within one Month of Treatment
- China Biopharmaceuticals Holdings Initiates Clinical Trials of Sofalcone for Treatment of Digestive Ulcers
- China Biopharmaceuticals Holdings Initiates Clinical Trials of Sofalcone for Treatment of Digestive Ulcers
- Article
- Centre Daily Times | 10/30/2006 | Cure for high drug costs
- GeoPharma Announces Schering-Plough Lawsuit Related to Generic Version of Clarinex(R): Financial News - Yahoo!Finance
- United Press International - Health Business - Schering challenges generic Clarinex
- Daytrading, Eminis, Forex trading, Swing Trading BREAKING NEWS - 449017
- Daytrading, Eminis, Forex trading, Swing Trading STOCK ALERT - 449636
- Daytrading, Eminis, Forex trading, Swing Trading BREAKING NEWS - 449050
- Business: Clarinex producer sues over generics
- Drug firms' tactics exposed
- GeoPharma Announces Schering-Plough Lawsuit Related to Generic Version of Clarinex(R)
- More Clarinex News Articles...
- Aerospan, Clarinex-D 12-hour tablets.(New & Approved) : An article from: Family Practice News
- Desloratadine safe for use in infants and young children: allergic rhinitis.(Clinical Rounds): An article from: Pediatric News
- Desloratadine for allergic rhinitis safe for infants and young: placebo-controlled trial.(Children's Health): An article from: Family Practice News
- Synagis, Clarinex Syrup.(New & Approved)(drug approval): An article from: Pediatric News
- Clarinex-D 24 hour, fluzone.(New & Approved): An article from: Pediatric News
- Clarinex. (New & Approved).: An article from: Family Practice News
- New & Approved: Clarinex, Procleix. (RX).: An article from: Internal Medicine News
- Aerospan, Clarinex-D.(New & Approved) : An article from: Pediatric News
- Fluzone, Clarinex-D 24 hour.(New & Approved): An article from: Family Practice News
- Seasonal allergic rhinitis: desloratadine boosts quality of life, reduces symptoms.(Clinical Rounds): An article from: Internal Medicine News
- Desloratadine appears safe for infants and young children: results of placebo-controlled trial.(Dermatologic Therapy): An article from: Skin & Allergy News
- Europeans Enthusiastic About Desloratadine. (UNDER FDA REVIEW).(for treating chronic idiopathic urticaria): An article from: Skin & Allergy News
- CHINA BIOPHARMACEUTICALS COMPLETES DESLORATADINE TRIALS.: An article from: Worldwide Biotech






